Aurobindo Pharma’s stock shows resistance at Rs 1177, with a promising technical outlook. Traders are advised to consider a Bull Call Spread strategy proposed by Mehta for potential upside movements.
Private sector banks are the best contrarian bet for the next 3 years, says S Naren
ICICI Prudential AMC CIO S Naren warned that rising leverage through derivatives and margin trading poses a bigger risk than any slowdown in mutual fund